scholarly journals The design and synthesis of a pyrrole-carbaldehyde hit family as HIV-1 integrase inhibitors

Author(s):  
Telisha Traut ◽  
Raymond Hewer ◽  
Judy Coates ◽  
D. Bradley G. Williams

Screening of an HIV-1 IN model against database-derived chemical structures identified pyrrole-carbaldehydes as targets for further development. Chemical synthesis using a facile one-pot reaction resulted in the generation of a compound library. Preliminary toxicity and efficacy assays of the water-soluble HCl-salt derivatives of each compound support the in silico predictions.

Molecules ◽  
2008 ◽  
Vol 13 (10) ◽  
pp. 2442-2461 ◽  
Author(s):  
Mario Sechi ◽  
Ugo Azzena ◽  
Maria Paola Delussu ◽  
Roberto Dallocchio ◽  
Alessandro Dessì ◽  
...  

Acta Naturae ◽  
2013 ◽  
Vol 5 (1) ◽  
pp. 63-72 ◽  
Author(s):  
S. P. Korolev ◽  
O. V. Kondrashina ◽  
D. S. Druzhilovsky ◽  
A. M. Starosotnikov ◽  
M. D. Dutov ◽  
...  

Human immunodeficiency virus type 1 integrase is one of the most attractive targets for the development of anti-HIV-1 inhibitors. The capacity of a series of 2,1,3-benzoxadiazoles (benzofurazans) and their N-oxides (benzofuroxans) selected using the PASS software to inhibit the catalytic activity of HIV-1 integrase was studied in the present work. Only the nitro-derivatives of these compounds were found to display inhibitory activity. The study of the mechanism of inhibition by nitro-benzofurazans/benzofuroxans showed that they impede the substrate DNA binding at the integrase active site. These inhibitors were also active against integrase mutants resistant to raltegravir, which is the first HIV-1 integrase inhibitor approved for clinical use. The comparison of computer-aided estimations of the pharmacodynamic and pharmacokinetic properties of the compounds studied and raltegravir led us to conclude that these compounds show promise and need to be further studied as potential HIV-1 integrase inhibitors.


2019 ◽  
Vol 30 (1) ◽  
pp. 247-249 ◽  
Author(s):  
Xingjie Zhang ◽  
Zhi Meng ◽  
Zhiqiang Ma ◽  
Junhong Liu ◽  
Guiyan Han ◽  
...  

2004 ◽  
Vol 47 (21) ◽  
pp. 5298-5310 ◽  
Author(s):  
Mario Sechi ◽  
Massimiliano Derudas ◽  
Roberto Dallocchio ◽  
Alessandro Dessì ◽  
Alessia Bacchi ◽  
...  

ChemInform ◽  
2004 ◽  
Vol 35 (23) ◽  
Author(s):  
Xuechun Zhang ◽  
Christophe Marchand ◽  
Yves Pommier ◽  
Terrence R. Jr. Burke

2011 ◽  
Vol 66 (9) ◽  
pp. 953-960 ◽  
Author(s):  
Najim A. Al-Masoudi ◽  
Nadhir N. A. Jafar ◽  
Layla J. Abbas ◽  
Sadiq J. Baqir ◽  
Christophe Pannecouque

There is an urgent need for the design and development of new and safer drugs for the treatment of HIV infection, active against the currently resistant viral strains. New derivatives of the non-steroidal anti-inflammatory drug indomethacin bearing benzimidazoles, benzothiazole, purine and pyridine residues 8 - 13 were synthesized with the aim of developing new non-nucleoside reverse transcriptase inhibitors (NNRTIs).Alternatively, new imine analogs 16 - 20 were synthesized from condensation of indomethacinyl hydrazide 15, prepared from the ester 14, with various ketone precursors. Treatment of 15 with phenyl isothiocyanate or triethyl orthoformate afforded the phenylcarbonothioyl and the oxadiazole derivatives 21 and 22, respectively. The new compounds were assayed against HIV-1 and HIV-2 in MT-4 cells. Compounds 9 and 10 were the most active in inhibiting HIV-2 and HIV-1, respectively, with EC50 ≥ 17.60 μgmL−1 and > 1.15 μgmL−1 (therapeutic indexes (SI) of ≥ 3 and < 1, respectively), and are leading candidates for further development.


2008 ◽  
Vol 51 (4) ◽  
pp. 861-874 ◽  
Author(s):  
Ester Muraglia ◽  
Olaf Kinzel ◽  
Cristina Gardelli ◽  
Benedetta Crescenzi ◽  
Monica Donghi ◽  
...  

2004 ◽  
Vol 12 (9) ◽  
pp. 2317-2333 ◽  
Author(s):  
Mahindra T Makhija ◽  
Rajesh T Kasliwal ◽  
Vithal M Kulkarni ◽  
Nouri Neamati

2009 ◽  
Vol 17 (7) ◽  
pp. 2925-2935 ◽  
Author(s):  
Mario Sechi ◽  
Giuseppe Rizzi ◽  
Alessia Bacchi ◽  
Mauro Carcelli ◽  
Dominga Rogolino ◽  
...  

2008 ◽  
Vol 18 (2) ◽  
pp. 721-725 ◽  
Author(s):  
H. Marie Langford ◽  
Peter D. Williams ◽  
Carl F. Homnick ◽  
Joseph P. Vacca ◽  
Peter J. Felock ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document